ShapeShapeauthorShapechevroncrossShapeShapeShapeGrouphamburgerhomeGroupmagnifyShapeShapeShaperssShape

Acquisition of Pfizer Assets by Lilly Cleared

by 5m Editor
25 May 2010, at 11:30am

EU - The European Commission has cleared the acquisition of animal health assets of Pfizer by Eli Lilly & Co.

The European Commission has granted clearance under the EU Merger Regulation to the acquisition of animal health assets of Pfizer by Eli Lilly & Co, both of the US.

Eli Lilly is a research-based, global pharmaceutical company engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products for humans and animals. Pfizer is active in the production of vaccines for animals.

The operation was examined under the simplified merger review procedure.

Further Reading

- Go to our previous news item on this story by clicking here.